VAERS reports by lot

Merck Pneumococcal lot T016159: VAERS reports

35 VAERS reports list lot T016159 as a Merck Pneumococcal vaccine, received between 2020-10-10 and 2023-02-21. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
35
Reports
9%
Marked serious
0
With a death outcome
13
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction3527%
General / Systemic (non-local)2822%
Cardiac / Cardiovascular2016%
Musculoskeletal1713%
Allergic / Anaphylactic97%
Neurological65%
Dermatological (non-injection-site)65%
Respiratory32%
Gastrointestinal32%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California9
Colorado7
Arizona5
Oregon3
Nevada2
New Mexico2
Washington1
Idaho1
Montana1
Alaska1
Hawaii1
Wyoming1

Reports by month received

2020-104
2020-118
2020-127
2021-012
2021-023
2021-031
2021-061
2021-071
2021-082
2021-093
2021-121
2022-071
2023-021

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.